(Q422970)

promethazine (English)

3 October 2016

chemical formula

C₁₇H₂₀N₂S

1 reference

promethazine (English)

19 November 2016

canonical SMILES

CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C

1 reference

promethazine (English)

https://www.whocc.no/atc_ddd_index/?code=R06AD02

19 November 2016

defined daily dose

25 milligram

route of administration

oral administration

1 reference

reference URL

25 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=R06AD02

25 milligram

route of administration

rectal route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=R06AD02

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

promethazine (English)

1 reference

promethazine (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

postoperative complications

13 December 2016

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

disopyramide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hyperpyrexia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ileus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

xerostomia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Histamine receptor H1

subject has role

antagonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7282

Australian pregnancy category C

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Promethazine

16 January 2017

1 reference

Medical Subject Headings

15 March 2018

1 reference

5 March 2018

2 references

5 March 2018

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

2934.30.30

0 references

0 references

0 references

0 references

Promethazine

0 references

Identifiers

InChI

InChI=1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3

1 reference

promethazine (English)

19 November 2016

2 references

promethazine (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

60-87-7

2 references

promethazine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=60-87-7

9 April 2021

1 reference

(±)-Promethazine (English)

19 November 2016

2 references

promethazine (English)

19 November 2016

Reaxys registry number

88554

1 reference

promethazine (English)

3 October 2016

Gmelin number

337077

0 references

ChEBI ID

8461

mapping relation type

2 references

PROMETHAZINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3

1 reference

PROMETHAZINE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Fac_Eng_Univ_Tokyo-JP003182

1 reference

MassBank accession ID

SM849001

0 references

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003830

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP005772

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP005784

0 references

MSBNK-Waters-WA002185

0 references

MSBNK-Waters-WA002186

0 references

MSBNK-Waters-WA002187

0 references

MSBNK-Waters-WA002188

0 references

MSBNK-Waters-WA002189

0 references

MSBNK-Waters-WA002190

0 references

SPLASH

splash10-00di-9000000000-abbdf5514dccef4821b2

0 references

splash10-00di-9100000000-9bef9a6b83d662fc7e2c

0 references

splash10-0079-8290000000-fe5d6b4e9f62b7270798

0 references

splash10-000i-9220000000-9d761be1437f10dcc94b

0 references

splash10-00di-9210000000-7167670dff3395a6ade2

0 references

NMRShiftDB structure ID

20209869

1 reference

Hazardous Substances Data Bank

0 references

1 reference

28 October 2019

Promethazine (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

promethazine (English)

ECHA Substance Infocard ID

19 November 2016

100.000.445

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.000.445

27 December 2018

Promethazine (English)

quotation

CAS no.: 60-87-7 (English)

1 reference

Promethazine (English)

17 November 2015

1 reference

Guide to Pharmacology Ligand ID

Promethazine (English)

publication date

17 November 2015

7282

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7282

promethazine (English)

19 November 2016

Promethazine

0 references

0 references

0 references

0 references

1 reference

promethazine (English)

19 November 2016

DrugBank ID

DB01069

1 reference

Human Metabolome Database ID

HMDB0015202

2 references

based on heuristic

inferred from InChIKey

2 references

promethazine (English)

19 November 2016

MedlinePlus drug identifier

a682284

0 references

PatientsLikeMe treatment ID

0 references

1 reference

promethazine (English)

19 November 2016

0 references

1 reference

1 reference

promethazine (English)

3 October 2016

1 reference

electronic Essential Medicines List medicine ID

promethazine (English)

3 October 2016

1 reference

6 April 2020

0 references

0 references

1 reference

28 October 2013

Gran Enciclopèdia Catalana ID

prometazina

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0 references

1 reference

9 July 2020

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

1 reference

imported from Wikimedia project

1 reference

promethazine (English)

19 November 2016

WikiProjectMed ID

Promethazine

0 references

WordNet 3.1 Synset ID

04016724-n

1 reference